Literature DB >> 2424462

Increased proto-oncogene expression in peripheral blood lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases.

D T Boumpas, G C Tsokos, D L Mann, E G Eleftheriades, C C Harris, G E Mark.   

Abstract

Using RNA hybridization techniques, we examined the expression of proto-oncogenes associated with lymphocyte activation in vitro in patients with systemic lupus erythematosus and other autoimmune diseases. T and B lymphocytes from these patients were found to have significantly increased expression of c-myc, c-myb, and c-raf RNA when compared with those of normal individuals. Among the mononuclear cell subpopulations, B lymphocytes expressed higher levels of RNA for these proto-oncogenes compared with the T lymphocytes. Since prompt expression of these and other proto-oncogenes occurs in fibroblasts and lymphocytes following mitogenic stimulation, we propose that the present findings reflect the pathologically activated state of various lymphocytic subpopulations which is observed in systemic lupus erythematosus and in other autoimmune diseases. Endogenous and exogenous factors which lead to the expression of autoimmunity might share the induction of proto-oncogene expression as a common pathogenetic step.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2424462     DOI: 10.1002/art.1780290608

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  8 in total

1.  Increased risk of cancer in patients with systemic lupus erythematosus.

Authors:  T Pettersson; E Pukkala; L Teppo; C Friman
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

2.  Drosophila melanogaster homologs of the raf oncogene.

Authors:  G E Mark; R J MacIntyre; M E Digan; L Ambrosio; N Perrimon
Journal:  Mol Cell Biol       Date:  1987-06       Impact factor: 4.272

3.  Pks, a raf-related sequence in humans.

Authors:  G E Mark; T W Seeley; T B Shows; J D Mountz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

4.  C-myc gene binding factors in peripheral blood mononuclear cells from patients with systemic lupus erythematosus (SLE).

Authors:  Y Deguchi; S Negoro; T Hosokawa; S Kishimoto
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

5.  Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus.

Authors:  Ryan Webb; Jonathan D Wren; Matlock Jeffries; Jennifer A Kelly; Kenneth M Kaufman; Yuhong Tang; Mark Barton Frank; Joan Merrill; Robert P Kimberly; Jeffrey C Edberg; Rosalind Ramsey-Goldman; Michelle Petri; John D Reveille; Graciela S Alarcón; Luis M Vilá; Marta E Alarcón-Riquelme; Judith A James; Timothy J Vyse; Kathy L Moser; Patrick M Gaffney; Gary S Gilkeson; John B Harley; Amr H Sawalha
Journal:  Arthritis Rheum       Date:  2009-04

6.  Activated peripheral blood mononuclear cells detected by murine monoclonal antibodies to proliferating cell nuclear antigen in active lupus patients.

Authors:  A Murashima; Y Takasaki; M Ohgaki; H Hashimoto; T Shirai; S Hirose
Journal:  J Clin Immunol       Date:  1990-01       Impact factor: 8.317

7.  Clinical and laboratory observation systemic lupus erythematosus and acute lymphocytic leukemia: An unusual case.

Authors:  Anu Maheshwari; Meenu Pandey; Bimbadhar Rath; Jagdish Chandra; Smita Singh; Sunita Sharma
Journal:  Indian J Med Paediatr Oncol       Date:  2011-07

8.  Pemphigus erythematosus and cutaneous epitheliotropic lymphoma in a Labrador Retriever dog.

Authors:  A Suárez-Bonnet; B García-González; G A Ramírez; C Peñafiel-Verdú; J R Jaber
Journal:  Iran J Vet Res       Date:  2019       Impact factor: 1.376

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.